Skip to main content
Equibles

PANAGORA ASSET MANAGEMENT INC

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 883677 Boston, MA
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$5,963,967
-$172,005 QoQ
Shares Held
324,658
+3.5% QoQ
Ownership
0.287%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#55
of 215 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 32% Shared 0% None 68%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PANAGORA ASSET MANAGEMENT INC holds $623,499,718 across 77 Biotechnology names. VRDN ranks #21 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 175,291 $109,300,950
2 INCY
Incyte Corp
 881,889 $99,970,937
3 XENE
Xenon Pharmaceuticals Inc.
 664,031 $40,080,911
4 MIRM
Mirum Pharmaceuticals, Inc.
 337,461 $39,506,559
5 TVTX
Travere Therapeutics, Inc.
 490,724 $27,878,030
6 JAZZ
Jazz Pharmaceuticals plc
 104,935 $25,286,186
7 RLAY
Relay Therapeutics, Inc.
 1,291,182 $24,158,015
8 CLDX
Celldex Therapeutics, Inc.
 572,538 $21,304,138

All Filings in VRDN

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,963,967 324,658
2026-03-31 $6,135,972 313,700
2025-12-31 $10,106,095 324,746
2025-09-30 $8,151,003 377,711
2025-06-30 $4,918,890 351,852
2025-03-31 $4,781,881 354,739
2024-12-31 $4,850,431 253,022
2024-09-30 $3,831,850 168,433